ACOUSTIC NEUROMA DR.AYESHA FAYYAZ TR ENT, SZH
11-1-2018
DEFINITION • ALSO CALLED VESTIBULAR SCHWANNOMA • BENIGN, SLOW GROWING, NERVE SHEATH
TUMOR OF SUPERIOR AND INFERIOR VESTIBULAR NERVE
INTRODUCTION • 78% OF ALL A TUMORS • ARISES IN MEDIAL PART OF THE IAC OR THE LATERAL PART OF THE A
• AGE OF PRESENTATION: SPORADIC: 40-60 YR. NON-SPORADIC < 20-30 YR. • MEAN GROWTH RATE : 1.2 MM / YR. • RARELY MALIGNANT
ANATOMY OF ANGLE • POTENTIAL CSF SPACE IN POSTERIOR CRANIAL FOSSA • ROUGHLY TRIANGULAR IN SHAPE
• ANTERIORLY: TEMPORAL BONE • POSTERIORLY: CEREBELLUM • MEDIALLY: CISTERNS OF THE PONS &
MEDULLA AND OLIVE • SUPERIORLY: INFERIOR BORDER OF PONS & CEREBRAL PEDUNCLE
STRUCTURES CROSSING A • CN V ( SUPERIORLY ) • CN IX,X,XI ( INFERIORLY )
• CENTRE: CN VII AND VIII WITH ARACHNOID SHEATH TO IAC • AICA
ETIOLGY Defective chromosome 22q12
Mutated tumor suppressor “MERLIN”
Somatic mutation in both copies of MERLIN
U/L VS
GROSS ANATOMY • SMOOTH SURFACE • YELLOW TO GRAY COLOR
• USUALLY SOLID WITH OCCASIONAL CYSTIC COMPONENT
HISTOLOGY ANTONI A: • CLOSELY PACKED CELLS
• SMALL SPINDLE-SHAPED AND DENSELY STAINED NUCLEI • WHORLED APPEARANCE • VEROCAY BODY
ANTONI B: • LOOSE CELLULAR AGGREGATION OF VACUOLATED PLEOMORPHIC CELLS
CLASSIFICATION • ACCORDING TO SIZE
Intrameatal tumour
Extrameatal size
mm
Grade 1
Small
1-10
Grade 2
Medium
11-20
Grade 3
Moderately Large
21-30
Grade 4
Large
31-40
Grade 5
Giant
>40
SIGNS & SYMPTOMS INTRACANALICULAR: ◦ HEARING LOSS (UL PROGRESSIVE ), TINNITUS, VERTIGO
◦ LOSS OF SPEECH DISCRIMINATION OUT OF PROPORTION TO HL CISTERNAL: ◦ WORSENED HEARING AND DISEQUILIBRIUM
SIGNS & SYMPTOMS COMPRESSIVE: ◦ OCCASIONAL OCCIPITAL HEADACHE
◦ CN V: MIDFACE, CORNEAL HYPOESTHESIA ◦ CN VII : HITZELBERGER’S SIGN, LOSS OF TASTE AND REDUCED LACRIMATION ON SCHIRMER’S TEST , FACIAL WEAKNESS ( LATE) ◦ CN II , IV , VI : DEC. VISUAL ACUITY AND DIPLOPIA
SIGNS & SYMPTOMS HYDROCEPHALIC: ◦ FOURTH VENTRICLE COMPRESSED AND OBSTRUCTED
◦ HEADACHE, VISUAL CHANGES, ALTERED MENTAL STATUS ◦ NAUSEA AND VOMITING ◦ O/E : RAISED I AND PAPILLEDEMA.
COMPRESSION OF CN IX & X ◦ DYSPHAGIA , ASPIRATION AND HOARSENESS ◦ POOR GAG REFLEX AND VC PARALYSIS.
SIGNS & SYMPTOMS CEREBELLAR INVOLVEMENT( LATE ) ◦ INCOORDINATION , WIDELY BASED GAIT , TENDENCY TO FALL
TOWARDS AFFECTED SIDE
BRAINSTEM INVOLVEMENT:
• ATAXIA, WEAKNESS AND NUMBNESS OF ARMS AND LEGS WITH EXAGGERATED TENDON REFLEXES.
INVESTIGATIONS MRI WITH GADOLINIUM CONTRAST • HYPOINTENSE GLOBULAR MASS IN IAC ON T1
• ENHANCEMENT WITH GADOLINIUM • ISO/HYPOINTENSE ON T2
CT SCAN WITH IODINE CONTRAST • OVOID MASS IN IAC WITH NONHOMOGENEOUS ENHANCEMENT.
SPECIAL INVESTIGATIONS
AUDIOLOGY PURETONE AUDIOMETRY: • ASYMMETRIC, DOWNSLOPING, HIGH-FREQUENCY SNHL
WORD RECOGNITION SCORE (WRS): • ROLLOVER PHENOMENON
ACOUSTIC REFLEX THRESHOLDS • ACOUSTIC REFLEX DECAY
VESTIBULAR TESTING ELECTRONYSTAGMOGRAPHY (ENG) • REDUCED CALORIC RESPONSE IN THE PROBLEMATIC EAR
AUDITORY BRAINSTEM RESPONSE • MEASURES YOUR BRAIN'S RESPONSE TO SOUND • FULLY OR PARTIALLY ABSENT
• DELAY IN THE LATENCY OF WAVE V IN THE AFFECTED EAR • INTER AURAL DELAY OF WAVE V LATENCY > 0.2 MS • SENSITIVITY >90%
• SPECIFICITY = 90%
DIFFERENTIAL DIAGNOSIS D/D
S/S
INVESTIGATIONS
MENINGIOMA
LESS PROMINENT HL
NO EXPANSION OF IAC MAY HAVE DURAL TAIL (CT/MRI)
EPIDERMOID
LESS PROMINENT HL
NON-ENHANCHING T1 & T2 IMAGES
FACIAL NERVE SHWANNOMA
EARLY PROMINENT FACIAL WEAKNESS
ENHANCEMENT IN FACIAL CANAL
TRIGEMINAL SCHWANNOMA
LESS PROMINENT HL MORE PROMINENT FACIAL NUMBNESS
DUMBELL SHAPED MASS OVER PETROUS APEX
TREATMENT • SURGICAL REMOVAL • OBSERVATION
• RADIOTHERAPY
SURGICAL REMOVAL • TRANS LABYRINTHINE CRANIOTOMY • RETRO SIGMOIDAL CRANIOTOMY
• MIDDLE FOSSA CRANIOTOMY
TRANSLABYRINTHINE APPROACH • PRIMARY APPROACH • HEARING ABLATING METHOD
• PT SELECTION: POOR HEARING ( HL > 50DB) UNRESECTABLE WITH HEARING PRESERVING METHODS
STEPS
post-auricular incision
Mastoidectomy
Identification of incus, tegmen, sigmoid sinus & facial nerve
Skeletonization of middle and post fossa dura
sigmoid sinus decompressed with a diamond burr
Identification of facial nerve medial to bill’s bar
Tumor removal from lateral to medial side
ADVANTAGES
• ANY SIZE TUMOR CAN BE RESECTED
• MINIMUM BRAIN RETRACTION • FACIAL NERVE PRESERVATION: 97%
DISADVANTAGES
• HEARING LOSS
RETROSIGMOIDAL APPROACH • HEARING PRESERVING METHOD • GOOD VIEW OF A
• PT SELECTION: GOOD HEARING LEVELS TUMOR LIMITED TO MEDIAL IAC
STEPS
Retromastoid curvilinear skin incision
Mastoid & retromastoid bone exposed
Craniotomy performed
dura is opened along the sigmoid sinus
Cerebellum visualized & retracted
A identified
Posterior wall of IAC removed for exposure of canalicular portion
Closure done in layers
ADVANTAGES
• HEARING PRESERVATION
DISADVANTAGES
• PERSISTENT POST-OPERATIVE HEADACHE
• INABILITY TO EXPOSE FACIAL NERVE • PERSISTENT CSF LEAK
MIDDLE FOSSA APPROACH • HEARING PRESERVING APPROACH • INTRACANALICULAR TUMORS WITH <1.5 CM CISTERNAL COMPONENT
• ENTIRE IAC IS ACCESSIBLE WITHOUT VIOLATING THE INNER EAR • POOR SURGICAL POSITION OF THE FACIAL NERVE • TRANSIENT SPEECH AND MEMORY DISTURBANCES AND AUDITORY HALLUCINATIONS
STEPS
inverted U-shaped incision over the ear
Squamous temporal bone exposed
Cranioto my over zygomati c root
Extradura l elevation of temporal lobe
IAC identified and skeletoniz ed
Dura exposed posteriorl y in IAC
Tumor removed
Closure done in layers
OBSERVATION • LIFE EXPECTANCY < DURATION REQUIRED FOR VS GROWTH • RADIOLOGICAL FOLLOW-UP :
AFTER 6 MONTHS THEN YEARLY • TREATMENT: 2-3MM GROWTH / 1ST YEAR
STEREOTACTIC RADIATION • PRECISELY TARGETED HIGH DOSE RADIOTHERAPY • PREVENTS FURTHER GROWTH
• PRESERVE HEARING & FACIAL NERVE • COMPLICATION: HYDROCEPHALUS • PT SELECTION:
• SHORT LIFE EXPECTANCY • HIGH SURGICAL RISK
OPERATIVE COMPLICATIONS • VASCULAR INJURY • AIR EMBOLISMS
• PARENCHYMAL BRAIN INJURY • CRANIAL NERVE INJURY
THANKYOU